An ongoing commitment

Temerty Foundation’s $2.5-million gift strengthens ALS research

Tens of thousands of ALS patients and their caregivers could see their lives improve thanks to a substantial $2.5-million gift from the Temerty Foundation.

Designed to support and advance Amyotrophic Lateral Sclerosis (ALS) research at Western’s Schulich School of Medicine & Dentistry, the gift has researchers poised to make greater advances in ALS treatments than ever before.  

The funds established the Temerty Foundation RGNEF Research Fund for ALS, and helped implement a three-year study with an international team of researchers collectively led by Distinguished University Professor Dr. Michael J. Strong from his lab at the Robarts Research Institute.

Jim and Louise Temerty

“We have always looked for opportunities to make a difference by supporting the best research at the best institutions,” said Jim Temerty, founder and chairman of Northland Power Inc.

“We’re thrilled to invest in Western’s outstanding ALS research, and to foster international collaboration to further strengthen the team.”

Louise and Jim Temerty

Combined with a previous $5-million donation in 2014, the gift brings the Temerty Foundation’s total investment in Western to $7.5 million.

“We have always looked for opportunities to make a difference by supporting the best research at the best institutions,” said Jim Temerty, founder and chairman of Northland Power Inc. “We’re thrilled to invest in Western’s outstanding ALS research, and to foster international collaboration to further strengthen the team.”